Pathology of familial Alzheimer’s disease with Lewy bodies

  • T. Revesz
  • J. L. McLaughlin
  • M. N. Rossor
  • P. L. Lantos
Part of the Journal of Neural Transmission. Supplementa book series (NEURAL SUPPL, volume 51)


The neuropathological findings of three cases from two pedigrees with early onset familial Alzheimer’s disease (FAD) are reported. Affected members of the first family, including cases 1 and 2 reported here, are known to have 717 valine to isoleucine mutation of the amyloid precursor protein (APP) gene, while the genetic background of the disease has not been clarified yet in the second family. In all three cases, in addition to the classical histological findings associated with Alzheimer’s disease (AD), both nigral and cortical Lewy bodies (LBs) occurred.

The association of LBs with AD type pathology, which may be observed in both sporadic and familial AD, raises important nosological issues. These include a possible overlap between AD and other neurodegenerative conditions presenting primarily with LBs. In this respect the clinically and neuropathologically distinct disease entity described under the terms of “senile dementia of the Lewy body type” and “Lewy body variant of AD” may be especially important. The occurrence of LBs in association with severe AD-type histological changes in sporadic and especially in some familial AD cases indicate that these inclusions may be another expression of the altered cytoskeleton in AD.


Lewy Body Senile Dementia Dystrophic Neurites Amyloid Precursor Protein Gene Body Variant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Azzarelli B, Muller J, Ghetti B, Dyken M, Conneally PM (1985) Cerebellar plaques in familial Alzheimer’s disease (Gerstmann-Straussler-Scheinker variant). Acta Neuropathol (Berl) 65: 235–246.CrossRefGoogle Scholar
  2. Bird TD (1994) Familial Alzheimer’s disease. Ann Neurol 36: 335–336.PubMedCrossRefGoogle Scholar
  3. Bodhireddy S, Dickson DW, Mattiace L, Weidenheim KM (1994) A case of Down’s syndrome with diffuse Lewy body disease and Alzheimer’s disease. Neurology 44: 159–161.PubMedCrossRefGoogle Scholar
  4. Braak H, Braak E (1994) Pathology of Alzheimer’s disease. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 585–613.Google Scholar
  5. Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J, Mullan M (1991) Early-onset Alzheimer’s disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 353: 844–846 Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261: 921–923.Google Scholar
  6. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, HAines JL, Pericak-vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261: 921–923PubMedCrossRefGoogle Scholar
  7. Ditter SM, Mirra SS (1987) Neuropathologic and clinical features of Parkinson’s disease in Alzheimer’s disease patients. Neurology 37: 754–760.PubMedCrossRefGoogle Scholar
  8. Duffy P, Mayeux R, Kupsky W (1988) Familial Alzheimer’s disease with myoclonus and “spongy change”. Arch Neurol 45: 1097–1100.PubMedCrossRefGoogle Scholar
  9. Forno LS (1982) Pathology of Parkinson’s disease. In: Marsden CD, Fahn S (eds) Movement disorders. Butterworth Scientific, London, pp 25–40.Google Scholar
  10. Gentleman SM, Williams B, Royston MC, Jagoe R, Clinton J, Perry RH, Ince PG, Allsop D, Polak JM, Roberts GW (1992) Quantification of beta A4 protein deposition in the medial temporal lobe: a comparison of Alzheimer’s disease and senile dementia of the Lewy body type. Neurosci Lett 142: 9–12.PubMedCrossRefGoogle Scholar
  11. Gibb WR, Mountjoy CQ, Mann DMA, Lees AJ (1989) A pathological study of the association between Lewy body disease and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 52: 701–708.PubMedCrossRefGoogle Scholar
  12. Goate A, Chartier-Harlin MCM, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349: 704–706.PubMedCrossRefGoogle Scholar
  13. Hansen LA, Masliah E, Terry RD, Mirra SS (1989) A neuropathological subset of Alzheimer’s disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol 78: 194–201.PubMedCrossRefGoogle Scholar
  14. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M, Rice V, Butters N, Alford M (1990) The Lewy body variant of Alzheimer’s disease: a clinical and pathological entity. Neurology 40: 1–8.PubMedCrossRefGoogle Scholar
  15. Hansen LA, Galasko D, Samuel W, Xia Y, Chen X, Saitoh T (1994) Apolipoprotein-E epsilon-4 is associated with increased neurofibrillary pathology in the Lewy body variant of Alzheimer’s disease. Neurosci Lett 182: 63–65.PubMedCrossRefGoogle Scholar
  16. Hardy J, Crook R, Prihar G, Roberts G, Raghavan R, Perry R (1994) Senile dementia of the Lewy body type has an apolipoprotein E epsilon 4 allele frequency intermediate between controls and Alzheimer’s disease. Neurosci Lett 182: 1–2.PubMedCrossRefGoogle Scholar
  17. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181–184.PubMedCrossRefGoogle Scholar
  18. Iseki E, Matsushita M, Kosaka K, Suzuki K, Amano N, Saito A (1990) Morphological characteristics of senile plaques in familial Alzheimer’s disease. Acta Neuropathol (Beri) 80: 227–232.CrossRefGoogle Scholar
  19. Kazee AM, Han LY (1995) Cortical Lewy bodies in Alzheimer’s disease. Arch Pathol Lab Med 119: 448–453.PubMedGoogle Scholar
  20. Khachaturian ZS (1985) Diagnosis of Alzheimer’s disease. Arch Neurol 42: 1097–1105.PubMedCrossRefGoogle Scholar
  21. Kosaka K, Yoshimura M, Ikeda K, Budka H (1984) Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree — a new disease? Clin Neuropathol 3: 185–192.PubMedGoogle Scholar
  22. Kosaka K, Tsuchiya K, Yoshimura M (1988) Lewy body disease with and without dementia: a clinicopathological study of 35 cases. Clin Neuropathol 7: 299–305.PubMedGoogle Scholar
  23. Lantos PL (1992) Neuropathology of unusual dementias: an overview. In: Rossor MN (ed) Baillière’s clinical neurology, vol 1. Unusual dementias. Baillère Tindall, London, pp 485–516.Google Scholar
  24. Lantos PL, Luthert PJ, Hanger D, Anderton BH, Mullan M, Rossor M (1992) Familial Alzheimer’s disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer’s disease have the same cytoskeletal pathology. Neurosci Lett 137: 221–224 PubMedCrossRefGoogle Scholar
  25. Lantos PL, Ovenstone IM, Johnson J, Clelland CA, Roques P, Rossor MN (1994) Lewy bodies in the brain of two members of a family with the 717 (Val to Ile) mutation of the amyloid precursor protein gene. Neurosci Lett 172: 77–79.PubMedCrossRefGoogle Scholar
  26. Lennox G (1992) Lewy body dementia. In: Rossor MN (ed) Baillière’s clinical neurology, vol 1. Unusual dementias. Baillère Tindall, London, pp 653–676.Google Scholar
  27. Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin-Austen RB (1989) Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocy- tochemistry. J Neurol Neurosurg Psychiatry 52: 1236–1247.PubMedCrossRefGoogle Scholar
  28. Levy-Lahad E, Wijsman E, Nemens E, Anderson L, Goddard KAB, Weber JL, Bird TD, Schellenberg GD (1995a) A familial Alzheimer’s disease locus on chromosome 1. Science 269: 970–973.PubMedCrossRefGoogle Scholar
  29. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu C, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu Y-H, Guenette SY, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenberg GD, Tanzi RE (1995b) Candidate gene for the chromosome 1 familial Alzheimer’s disease locus. Science 269: 973–977.PubMedCrossRefGoogle Scholar
  30. Lippa CF, Smith TW, Swearer JM (1994) Alzheimer’s disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol 35: 81–88.PubMedCrossRefGoogle Scholar
  31. Martin JJ, Gheuens J, Bruyland M, Cras P, Vandenberghe A, Masters CL, Beyreuther K, Dom R, Ceuterick C, Lübke U, Van Heuverswijn H, De Winter G, Van Broeckhoven C (1991) Early-onset Alzheimer’s disease in 2 large Belgian families. Neurology 41: 62–68.PubMedCrossRefGoogle Scholar
  32. McLaughlin JE, Sankey EA, Revesz T (1993) Familial Alzheimer’s disease with Lewy bodies. Neuropathol Appl Neurobiol 19: 204.Google Scholar
  33. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer’s disease (CERAD), part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41: 479–486.Google Scholar
  34. Mullan M, Crawford F (1993) Genetic and molecular advances in Alzheimer’s disease. Trends Neurosci 16: 398–403.PubMedCrossRefGoogle Scholar
  35. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L (1992) A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N- terminus of beta-amyloid. Nat Genet 1: 345–347.PubMedCrossRefGoogle Scholar
  36. Murrell J, Farlow M, Ghetti B, Benson MD (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease. Science 254: 97–99.PubMedCrossRefGoogle Scholar
  37. Nee LE, Polinsky RJ, Eldridge R, Weingartner H, Smallberg S, Ebert M (1983) A family with histologically confirmed Alzheimer’s disease. Arch Neurol 40: 203–208.PubMedCrossRefGoogle Scholar
  38. Nochlin D, van-Belle G, Bird TD, Sumi SM (1993) Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer’s disease. Alzheimer Dis Assoc Disord 7: 212–222.PubMedGoogle Scholar
  39. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK (1990) Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 95: 119–139.Google Scholar
  40. Pro JD, Smith CH, Sumi SM (1980) Presenile Alzheimer disease: amyloid plaques in the cerebellum. Neurology 30: 820–825.PubMedCrossRefGoogle Scholar
  41. Raghavan R, Khin-Nu C, Brown A, Irving D, Ince PG, Day K, Tyrer SP, Perry RH (1993) Detection of Lewy bodies in Trisomy 21 (Down’s syndrome). Can J Neurol Sci 20: 48–51.PubMedGoogle Scholar
  42. Rossor M (1993a) Alzheimer’s disease. BMJ 307: 779–782.PubMedCrossRefGoogle Scholar
  43. Rossor M (1993b) Molecular pathology of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 56: 583–586.PubMedCrossRefGoogle Scholar
  44. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature 375: 754–760.PubMedCrossRefGoogle Scholar
  45. Struble RG, Polinsky RJ, Hedreen JC, Nee LE, Frommelt P, Feldman RG, Price DL (1991) Hippocampal lesions in dominantly inherited Alzheimer’s disease. J Neuropathol Exp Neurol 50: 82–94.PubMedCrossRefGoogle Scholar
  46. Woodard JS (1962) Concentric hyaline inclusion body formation in mental disease analysis of 27 cases. J Neuropathol Exp Neurol 21: 442–449.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1997

Authors and Affiliations

  • T. Revesz
    • 1
  • J. L. McLaughlin
    • 2
  • M. N. Rossor
    • 3
  • P. L. Lantos
    • 4
  1. 1.Department of NeuropathologyInstitute of NeurologyLondonUK
  2. 2.Royal Free HospitalLondonUK
  3. 3.Department of Clinical NeurologyInstitute of NeurologyLondonUK
  4. 4.Institute of PsychiatryLondonUK

Personalised recommendations